1-11 of 11
Dianna Howard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

Clinical Trials & Observations
Corey Cutler, Stephanie J. Lee, Sally Arai, Marcello Rotta, Behyar Zoghi, Aleksandr Lazaryan, Aravind Ramakrishnan, Zachariah DeFilipp, Amandeep Salhotra, Wanxing Chai-Ho, Rohtesh Mehta, Trent Wang, Mukta Arora, Iskra Pusic, Ayman Saad, Nirav N. Shah, Sunil Abhyankar, Carlos Bachier, John Galvin, Annie Im, Amelia Langston, Jane Liesveld, Mark Juckett, Aaron Logan, Levanto Schachter, Asif Alavi, Dianna Howard, Harlan W. Waksal, John Ryan, David Eiznhamer, Sanjay K. Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Pavletic
Journal: Blood
Blood (2021) 138 (22): 2278–2289.
https://doi.org/10.1182/blood.2021012021
Published: 2021
Includes: Supplemental data
Journal Articles

TCA Cycle Inhibition By Cpi-613 Increases Sensitivity to Chemotherapy in Older and Poor Risk Acute Myeloid Leukemia (AML)

Timothy S Pardee, MD PhD, Lance D Miller, PhD, Kristin Pladna, MS, Scott Isom, MS, Leslie Renee Ellis, MD, Dmitriy Berenzon, MD, Dianna Howard, MD, Megan Manuel, MSN, Sarah Dralle, MSN, Susan Lyerly, PA-C, Bayard L Powell, MD
Journal: Blood
Blood (2016) 128 (22): 4062.
https://doi.org/10.1182/blood.V128.22.4062.4062
Published: 2016
Journal Articles

The Mitochondrial Metabolism Inhibitor Cpi-613 in Combination with High Dose Ara-C (HDAC) and Mitoxantrone Is Highly Active in Poor Risk Relapsed or Refractory Acute Myeloid Leukemia (AML)

Timothy Pardee, MD PhD, Kristin Pladna, MS, Scott Isom, MS, Leslie Renee Ellis, MD, Dmitriy Berenzon, MD, Dianna Howard, MD, Megan Manuel, MSN, Sarah Dralle, MSN, David D Hurd, MD, Susan Lyerly, PA-C, Bayard L Powell, MD
Journal: Blood
Blood (2015) 126 (23): 2556.
https://doi.org/10.1182/blood.V126.23.2556.2556
Published: 2015
Journal Articles

Feasibility of a Symptom-Adapted Physical Activity Intervention during Induction Chemotherapy for Older Adults with Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Janet Tooze, PhD, Timothy Pardee, MD PhD, Leslie Renee Ellis, MD, Dmitriy Berenzon, MD, Dianna Howard, MD, Wendy Demark-Wahnefried, PhD, Shannon Mihalko, PhD, William Jack Rejeski, PhD, Bayard L. Powell, MD, Stephen Kritchevsky, PhD
Journal: Blood
Blood (2015) 126 (23): 2102.
https://doi.org/10.1182/blood.V126.23.2102.2102
Published: 2015
Journal Articles

Is Rituximab Needed With High Dose Chemotherapy and Autologous Stem Cell Transplant When Patients With Non-Hodgkin’s Lymphoma Have Been Exposed To It?

Zartash Gul, MD, Stephan Anderson, MD, Stacey Slone, Saurabh Chhabra, MD, Gregory Monohan, MD, Dianna Howard, MD, Amber Lawson, PharmD, John Hayslip, MD
Journal: Blood
Blood (2013) 122 (21): 5552.
https://doi.org/10.1182/blood.V122.21.5552.5552
Published: 2013
Journal Articles

MRP1 Plays a Role in Regulating Hematopoietic Stem Cell Oxidative Stress and Differentiation Via MRP1-Dependent Gsh Efflux

Cassandra J Reiling, B.A., Dianna Howard, MD, Christian M Paumi, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 1223.
https://doi.org/10.1182/blood.V120.21.1223.1223
Published: 2012
Journal Articles

A Phase 2 Study of Bortezomib Combined with Reinduction Chemotherapy in Children and Young Adults with Recurrent, Refractory or Secondary Acute Myeloid Leukemia: A Children's Oncology Group (COG) Study

Terzah M. Horton, MD, PhD, John Perentesis, MD, Alan S. Gamis, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Jennifer Ballard, CRA, Kathleen Adlard, RN, Dianna Howard, MD, Franklin O. Smith, MD, Jeffrey A. Moscow, MD
Journal: Blood
Blood (2012) 120 (21): 3580.
https://doi.org/10.1182/blood.V120.21.3580.3580
Published: 2012
Journal Articles

A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) As Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report On the Poor Risk Patients

Sucha Nand, MD, Megan Othus, PhD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Thomas Norwood, Harry Paul Erba, MD, PhD, Dianna Howard, MD, Steven E. Coutre, MD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2012) 120 (21): 3584.
https://doi.org/10.1182/blood.V120.21.3584.3584
Published: 2012
Journal Articles

A Phase I Study of the Combination of Azacitidine, Cyclophosphamide, Vincristine, and Rituximab in Relapsed and Refractory Lymphoma

Jessica J. Moss, MD, Dianna Howard, MD, Emily Van Meter, Ph.D., John Hayslip, MD
Journal: Blood
Blood (2011) 118 (21): 1624.
https://doi.org/10.1182/blood.V118.21.1624.1624
Published: 2011
Journal Articles

A Phase I study using Bortezomib with Weekly Idarubicin for the Treatment of Elderly (>60 YEARS) and Relapsed Patients with Acute Myeloid Leukemia (AML)

Dianna Howard, MD, Jane Liesveld, MD, Gordon L. Phillips, II, MD, Monica L. Guzman, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2008) 112 (11): 2953.
https://doi.org/10.1182/blood.V112.11.2953.2953
Published: 2008
Journal Articles

Gelclair® for the Treatment of Chemotherapy-Induced Stomatitis in Transplant and Hematology Patients: An Interim Analysis.

Susanne E. Liewer, PharmD, Keith A. Hecht, PharmD, Courtney F. Smith, PharmD, David L. DeRemer, PharmD, Dianna Howard, MD, Randy A. Brown, MD, Roger H. Herzig, MD, Val R. Adams, PharmD
Journal: Blood
Blood (2004) 104 (11): 5317.
https://doi.org/10.1182/blood.V104.11.5317.5317
Published: 2004